Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

Last updated: May 2, 2025
Sponsor: University of Michigan
Overall Status: Active - Recruiting

Phase

N/A

Condition

Scleroderma

Treatment

Brain Boost group

Waitlist group

Clinical Study ID

NCT06880627
HUM00267401
  • Ages 18-70
  • All Genders

Study Summary

The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being.

The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Have physician-diagnosis of Systemic sclerosis (SSc) (any subtype)

  • A score of ≥ 10 on the Perceived Deficits Questionnaire

  • A score of ≤ 7 on the 6-Item Cognitive Impairment Test

  • Have access to a reliable, internet-connected device (e.g. computer, smartphone,tablet)

  • Visual acuity with correction sufficient to work on a computer, smartphone, tabletor screen

  • Be able to read, speak, and understand English

Exclusion

Exclusion Criteria:

  • Diagnosis of dementia or head injury

  • Other neurological disorders that might impact cognition

  • Have major psychiatric disorder such as major depression and schizophrenia

  • Complex, unstable health issues that would preclude full participation in the study (like a planned surgery or active cancer treatment)

Study Design

Total Participants: 66
Treatment Group(s): 2
Primary Treatment: Brain Boost group
Phase:
Study Start date:
April 16, 2025
Estimated Completion Date:
June 30, 2027

Connect with a study center

  • University of Michigan

    Ann Arbor, Michigan 48109
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.